JAZZ

Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)

About Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Details

Daily high

$244.48

Daily low

$238.53

Price at open

$240.87

52 Week High

$266.38

52 Week Low

$125.78

Market cap

15.6B

Dividend yield

Volume

499,163

Avg. volume

1.1M

P/E ratio

16.60

Jazz Pharmaceuticals plc - Ordinary Shares News